Publications by authors named "Kensuke Asaba"

Claim this Profile
S
Systematic proteome-wide Mendelian randomization to prioritize causal plasma proteins for skin cancers.
Masahiro Yoshikawa, Tomohiro Nakayama, Kensuke Asaba

Commun Biol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCN3/NOV as a potential therapeutic target for diverticular disease: A proteome-wide Mendelian randomization study.
Masahiro Yoshikawa, Kensuke Asaba

Medicine (Baltimore)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritization of nasal polyp-associated genes by integrating GWAS and eQTL summary data.
Masahiro Yoshikawa, Kensuke Asaba, Tomohiro Nakayama

Front Genet· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating causal effects of genetically predicted type 2 diabetes on COVID-19 in the East Asian population.
Masahiro Yoshikawa, Kensuke Asaba, Tomohiro Nakayama

Front Endocrinol (Lausanne)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian randomization study.
Masahiro Yoshikawa, Kensuke Asaba, Tomohiro Nakayama

PLoS One· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
Masahiro Yoshikawa, Kensuke Asaba, Tomohiro Nakayama

BMC Med Genomics· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Educational Attainment Decreases the Risk of COVID-19 Severity in the European Population: A Two-Sample Mendelian Randomization Study.
Masahiro Yoshikawa, Kensuke Asaba

Front Public Health· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The APLNR gene polymorphism rs7119375 is associated with an increased risk of development of essential hypertension in the Chinese population: A meta-analysis.
Masahiro Yoshikawa, Kensuke Asaba, Tomohiro Nakayama

Medicine (Baltimore)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-nucleotide polymorphism rs4664308 in PLA2R1 gene is associated with the risk of idiopathic membranous nephropathy: a meta-analysis.
Masahiro Yoshikawa, Kensuke Asaba

Sci Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The reduced expression of proximal tubular transporters in acquired Fanconi syndrome with κ light chain deposition.
Akihiro Tojo, Kensuke Asaba, Satoshi Kinugasa, Yoichiro Ikeda, Yukako Shintani

Med Mol Morphol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The resistive index is a marker of renal function, pathology, prognosis, and responsiveness to steroid therapy in chronic kidney disease patients.
Kikuno Hanamura, Akihiro Tojo, Satoshi Kinugasa, Kensuke Asaba, Toshiro Fujita

Int J Nephrol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Kikuno Hanamura, Akihiro Tojo, Satoshi Kinugasa, Kensuke Asaba, Maristela Lika Onozato

Hum Pathol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term renal prognosis of IgA nephropathy with therapeutic trend shifts.
Kensuke Asaba, Akihiro Tojo, Maristela Lika Onozato, Satoshi Kinugasa, Hiroki Miyazaki

Intern Med· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressing renal NADPH oxidase to treat diabetic nephropathy.
Akihiro Tojo, Kensuke Asaba, Maristela L Onozato

Expert Opin Ther Targets· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-edged action of SOD mimetic in diabetic nephropathy.
Kensuke Asaba, Akihiro Tojo, Maristela Lika Onozato, Atsuo Goto, Toshiro Fujita

J Cardiovasc Pharmacol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spironolactone with ACE inhibitor is effective in gross hematuria caused by nephroptosis.
Akihiro Tojo, Maristela Lika Onozato, Kensuke Asaba, Toshiro Fujita

Int J Urol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of NADPH oxidase inhibitor in diabetic nephropathy.
Kensuke Asaba, Akihiro Tojo, Maristela Lika Onozato, Atsuo Goto, Mark T Quinn

Kidney Int· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitric oxide generated by nNOS in the macula densa regulates the afferent arteriolar diameter in rat kidney.
Akihiro Tojo, Maristela Lika Onozato, Satoru Fukuda, Kensuke Asaba, Kenjiro Kimura

Med Electron Microsc· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrillary glomerulonephritis associated with essential thrombocytosis.
Kensuke Asaba, Akihiro Tojo, Maristela Lika Onozato, Natsuko Mimura, Makiko Kido

Clin Exp Nephrol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis